课题基金 / 基金详情

A5401 COVID Supplement

A5401 COVID Supplement
A5401 新冠肺炎补充剂
批准号：
10203227
负责人：
Grace M Aldrovandi
金额：
$377.0万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-07-09 至 2021-11-30
来源：
https://reporter.nih.gov/project-details/10203227
关键词：
AIDS clinical trial groupAIDS/HIV problemAddressBiological AssayBiological MarkersCOVID-19ClinicalClinical ResearchClinical TrialsCollaborationsDNA RepositoryEvaluationGenomicsHIVHealthImmunologyInternationalKnowledgeLaboratoriesLaboratory ResearchLeadLeadershipMeasuresMonoclonal AntibodiesOutpatientsPathogenesisPatientsPharmacologyProceduresProtocols documentationResearchResearch PersonnelResearch PriorityResearch SupportSafetyScientific Advances and AccomplishmentsSevere Acute Respiratory SyndromeSiteSpecimenSpeedStandardizationTestingTherapeuticTherapeutic InterventionTotal Quality ManagementTraining ProgramsUnited States National Institutes of Healthbasecoronavirus diseasedata managementhuman DNAimprovedinnovationlaboratory experiencenoveloperationprogramssmall moleculetherapeutic vaccinetreatment guidelines

项目摘要

项目成果

Grace M Aldrovandi的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The AIDS Clinical Trials Group (ACTG) has been selected to lead a Master Adaptive protocol under the Accelerating COVID-19 Therapeutic Interventions and Vaccine (ACTIV) Operation Warp Speed. This trial (ACTG 5401 or ACTIV-2) will evaluate multiple monoclonal antibodies and other small molecules for outpatient COVID treatment. The Laboratory Center will expand its efforts to include support for COVID-19 clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core C -Centralized Laboratory Support Core
Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Core C -Centralized Laboratory Support Core
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
  • 批准号：
    9920737
  • 项目类别：
  • 资助金额：
    $70.86万
  • 财政年份：
    2019
  • 负责人：
    Grace M Aldrovandi
  • 依托单位：
    UNIVERSITY OF WASHINGTON